相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
IL2RG / CD132抗体
Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, recombinant Rat IL2RG / CD132 (rR IL2RG / CD132; Catalog#80197-R08H; Q68FU6; Met1-Ala262). Total IgG was purified by Protein A affinity chromatography.
IL2RG / CD132抗体 Background
The interleukin 2 receptor (IL-2R) is a heterotrimeric protein expressed on the surface of certain immune cells, such as lymphocytes, which binds and responds to the cytokine IL-2. Three distinct chains of IL-2R, termed as α, β and γ, which are non-covalently associated are identified. The α and β chains are involved in binding IL-2, while signal transduction following cytokine interaction is carried out by the γ chain, along with the β subunit which are members of the type I cytokine receptor family. The α chain of the IL-2R can bind to the β chain before receptor interaction with IL-2. The γ chain alone has a very weak affinity for IL-2, but after the ligand is bound to the α/β heterodimer, the γ chain becomes recruited to the complex to form a very stable macromolecular quaternary ligand/receptor complex. It is proposed that the γ chain is common to the IL2, IL4, IL7, IL21 and probably also the IL13 receptors.
IL2RG / CD132抗体相关产品如下:xy-1848R alpha MSH促黑细胞激素α抗体
xy-4122R MAX proteinMyc基因相关X因子抗体
xy-1425R ASK1细胞凋亡信号调节激酶1抗体
xy-5424R MAP3K7IP3NFKB激活蛋白1抗体
xy-5425R phospho-MAX protein(Tyr123)磷酸化Myc基因相关X因子抗体
xy-1484R MTHFR亚甲基四氢叶酸还原酶MTHFR抗体
xy-1433R MEK1MEK1/MAPKK1抗体(N-端)
xy-0963R MTNR1B褪黑素受体1B抗体
xy-1422R MRP4多药耐药相关蛋白4抗体
xy-1437R MRP5多药耐药相关蛋白5抗体
xy-1824R Mitofilin线粒体内膜蛋白抗体
xy-1913R MMP-8基质金属蛋白酶-8/胶原酶2抗体
xy-1853R MMP-11基质金属蛋白酶11抗体
xy-1854R MMP-12基质金属蛋白酶-12抗体
xy-1855R MMP-15基质金属蛋白酶-15抗体
xy-1856R MMP-16基质金属蛋白酶-16抗体
xy-1862R MMP-17基质金属蛋白酶-17抗体
xy-1802R Moesin膜突蛋白抗体
xy-0886R Measles virus fusion protein麻疹病毒融合蛋白抗体
xy-9522R MPP1红细胞膜蛋白55抗体
xy-9339R MARCH5膜相关环指蛋白5抗体
xy-5481R phospho-MEF2C(Ser387)磷酸化肌细胞增强因子2C抗体
xy-13764R MRP63线粒体核糖体蛋白MRP63抗体
xy-5482R phospho-MEF2C(Thr20)磷酸化肌细胞增强因子2C抗体
xy-10250R MMP13基质金属蛋白酶13抗体
xy-11525R MICAL1酪氨酸单氧化酶微管相关蛋白MICAL抗体
xy-11513R MKS1梅克尔-格鲁伯综合征相关蛋白抗体
xy-6811R MUM1突变的黑色素瘤相关抗原1抗体
xy-6816R MAGEA10黑色素瘤相关抗原10抗体
xy-6301R MAP3K2丝裂原活化蛋白激酶激酶2抗体
xy-6626R GPR24G蛋白偶联受体24抗体
xy-6722R MAPK organizer 1丝裂原活化蛋白激酶组织蛋白1抗体
xy-6680R MEIS1同源盒蛋白Meis1抗体
xy-6679R MAOA单氨氧化酶A抗体
xy-8512R MSX1MSH同源蛋白1样蛋白抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验(杨希峰),Yang CY(杨春瑛) et al. Generation and characterization of monoclonal antibody against HIT3a (抗CD3单克隆抗体HIT3a的制备和特异性鉴定), Acta Academiae Medicinae Sinicae (中国医学科学院学报),1993, 15:157-162.[6] Xiong D S(熊冬生),Yang C Z(杨纯正),Shao X F(邵晓枫)et al. Generation
因为抗体的结合而减少;在人体血清中无游离的CD20存在;最重要的是B淋巴细胞瘤上的CD20少有内吞和脱落的发生[ 2-5 ] 。1997年,以CD20为靶点的嵌合抗CD20单克隆抗体Rituxan已获准应用于B细胞淋巴瘤的治疗[ 6 ]。HI47(IgG3)是我所于1990年研制成功的国内第一个抗CD20鼠源性单克窿抗体,第四届国际人类白细胞分化抗原会议将HI47命名为CD20+X[ 7 ] 。我们利用噬菌体显示技术从HI47杂交瘤细胞中克隆到抗CD20抗体HI47可变区基因,将该基因构建成为嵌合的抗
20B淋巴细胞表面的膜蛋白CD20对B淋巴细胞的增殖和分化具有调节作用[1]。由于CD20分子仅在前-B淋巴细胞、未成熟B淋巴细胞、成熟B淋巴细胞、激活B淋巴细胞中表达,而在浆细胞、淋巴多能干细胞以及其它组织均无CD20的表达[2,3,4],在人体血清中亦无游离CD20的存在[5],因此CD20可作为B淋巴细胞瘤治疗的一个理想治疗靶点。限制抗体临床使用的因素主要有抗体产生的免疫原性和抗体的生产能力是否能够满足临床需要。第四届国际人类白细胞分化抗原会议将鼠源性单克隆抗CD20抗体HI47(IgG3)正式命名为CD20+X
技术资料暂无技术资料 索取技术资料





